Abstract:Background: Intervertebral disc degeneration (IVDD) is a leading cause of low back pain (LBP). The pathological process of IVDD is associated with inflammatory reactions and extracellular matrix (ECM) disorders. Digoxin is widely used for treating heart failure, and it has been reported to have anti-inflammatory effects. Objective: This study is to investigate the role of digoxin in the pathogenesis of intervertebral disc degeneration as well as the involved molecular mechanism, particularly the potential target protein. Methods: We exploited a rat needle model to investigate digoxin's role in intervertebral disc degeneration in vivo . Safranin O staining was used to measure cartilaginous tissue in the intervertebral disc. The morphological changes of intervertebral discs in animal models were determined by Hematoxylin-Eosin (H&E) staining and the pathological score. Primary nucleus pulposus cells (NP cells) from intervertebral discs of patients and murine were used in the present study. Western-Blotting assay, Real-time PCR assay, immunofluorescence staining, and immunochemistry were used to detect the role of digoxin in anti-TNF-α-induced inflammatory effects in vitro . Transfection of siRNA was used to regulate low-density lipoprotein receptor-related protein 4 (LRP4) expression in NP cells to investigate the potential protein target of digoxin. Results: Digoxin protected against intervertebral disc degeneration in rat needle models. Digoxin was found to exert its disc-protective effects through at least three different pathways by a) suppressing TNF-α-induced inflammation, b) attenuating ECM destruction, c) significantly promoting ECM anabolism. Additionally, LRP4 was found to be the downstream molecule of digoxin in NP cells for anti-inflammation and regulation of ECM metabolism. The knockdown of LRP4 downregulated the protective effect of digoxin in NP cells. Conclusion: These findings suggest that digoxin may be a potential therapeutic agent for intervertebral disc degeneration through anti-catabolism and pro-anabolism. Digoxin might also work as an alternative for other inflammation-related diseases.

Procyanidin B3 Alleviates Intervertebral Disc Degeneration Via Interaction with the TLR4/MD-2 Complex.

Dexmedetomidine Suppresses Oxidative Stress and Inflammation of Nucleus Pulposus Cells by Activating the PI3K/Akt Signaling Pathway.

Honokiol Alleviates the Degeneration of Intervertebral Disc Via Suppressing the Activation of TXNIP-NLRP3 Inflammasome Signal Pathway.

Baicalein Inhibits the IL-1β-Induced Inflammatory Response in Nucleus Pulposus Cells and Attenuates Disc Degeneration in Vivo.

1,25(OH)2D3 Mitigates Oxidative Stress-Induced Damage to Nucleus Pulposus-Derived Mesenchymal Stem Cells through PI3K/Akt Pathway

Spermidine promotes nucleus pulposus autophagy as a protective mechanism against apoptosis and ameliorates disc degeneration.

Polydatin suppresses nucleus pulposus cell senescence, promotes matrix homeostasis and attenuates intervertebral disc degeneration in rats

The Role of TGF‐β1/Smad2/3 Pathway in Platelet‐rich Plasma in Retarding Intervertebral Disc Degeneration

Inhibition of PP2A Ameliorates Intervertebral Disc Degeneration by Reducing Annulus Fibrosus Cells Apoptosis Via P38/mapk Signal Pathway.

Dehydrocostus Lactone Attenuates The Senescence Of Nucleus Pulposus Cells And Ameliorates Intervertebral Disc Degeneration Via Inhibition Of Sting-Tbk1/Nf-Kappa B And Mapk Signaling

Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-κB pathway in rats

Dehydrocostus Lactone Attenuates the Senescence of Nucleus Pulposus Cells and Ameliorates Intervertebral Disc Degeneration via Inhibition of STING-TBK1/NF-κB and MAPK Signaling

Ganoderic Acid A alleviates the degeneration of intervertebral disc via suppressing the activation of TLR4/NLRP3 signaling pathway

Dimethyl fumarate protects nucleus pulposus cells from inflammation and oxidative stress and delays the intervertebral disc degeneration

Sparstolonin B Prevents Lumbar Intervertebral Disc Degeneration Through Toll Like Receptor 4, NADPH Oxidase Activation and the Protein Kinase B Signaling Pathway.

Procyanidin B2 Alleviates Oxidative Stress-Induced Nucleus Pulposus Cells Apoptosis Through Upregulating Nrf2 Via PI3K-Akt Pathway

Curcumenol Mitigates the Inflammation and Ameliorates the Catabolism Status of the Intervertebral Discs <i>In Vivo</i> and<i> In Vitro via</i> Inhibiting the TNFa/NF?B Pathway

Curcumenol Mitigates the Inflammation and Ameliorates the Catabolism Status of the Intervertebral Discs In Vivo and In Vitro via Inhibiting the TNFα/NFκB Pathway

Icariin Protects Human Nucleus Pulposus Cells from Hydrogen Peroxide-Induced Mitochondria-Mediated Apoptosis by Activating Nuclear Factor Erythroid 2-Related Factor 2

Digoxin protects against intervertebral disc degeneration via TNF/NF-κB and LRP4 signaling

Cyanidin attenuates the apoptosis of rat nucleus pulposus cells and the degeneration of intervertebral disc via the JAK2/STAT3 signal pathway in vitro and in vivo